(Q79801204)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17311065%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

editorial

0 references

title

Hematopoietic stem cell transplants for chronic myeloid leukemia in Europe--impact of cost considerations (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17311065%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference

chronic myeloid leukemia

1 reference

1

Gratwohl A

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17311065%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

author name string

Baldomero H

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17311065%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Schwendener A

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17311065%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Gratwohl M

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17311065%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Urbano-Ispizua A

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17311065%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Frauendorfer K

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17311065%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

publication date

1 March 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17311065%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17311065%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17311065%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17311065%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

page(s)

383-386

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17311065%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.leu.2404509

25 December 2019

exact match

0 references

cites work

Hematopoietic stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404509

7 January 2021

Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404509

7 January 2021

Bone-marrow transplantation (second of two parts).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404509

7 January 2021

Blood and marrow transplantation compensation: perspective in payer and provider relations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404509

7 January 2021

Hematopoietic stem and progenitor cell transplants: regulation and accreditation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404509

7 January 2021

The importance of lowering the costs of stem cell transplantation in developing countries

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404509

7 January 2021

Economics, health care systems and utilization of haematopoietic stem cell transplants in Europe.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404509

7 January 2021

Hematopoietic stem cell transplantation for hematological malignancies in Europe.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404509

7 January 2021

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404509

7 January 2021

Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404509

7 January 2021

Chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404509

7 January 2021

Does early stem-cell transplantation have a role in chronic myeloid leukaemia? For the proposal

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404509

7 January 2021

Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404509

7 January 2021

The early referral for reduced-intensity stem cell transplantation in patients with Ph1 (+) chronic myelogenous leukemia in chronic phase in the imatinib era: results of the Latin American Cooperative Oncohematology Group (LACOHG) prospective, multi

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404509

7 January 2021

Allogeneic stem cell transplantation. An economic comparison of bone marrow, peripheral blood, and cord blood technologies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404509

7 January 2021

Cost-efficacy of imatinib versus allogeneic bone marrow transplantation with a matched unrelated donor in the treatment of chronic myelogenous leukemia: a decision-analytic approach

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404509

7 January 2021

Effectiveness and cost-effectiveness of imatinib for first-line treatment of chronic myeloid leukaemia in chronic phase: a systematic review and economic analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404509

7 January 2021

Transplanted technology: Third World options and First World science

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404509

7 January 2021

Chronic myeloproliferative disorders: a tyrosine kinase tale.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404509

7 January 2021

Nilotinib in imatinib-resistant CML and Philadelphia chromosome-positive ALL

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404509

7 January 2021

Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404509

7 January 2021